TY - CHAP A1 - Hassan, H. A1 - Ilgner, Justus F. R. A1 - Palm, Christoph A1 - Lehmann, Thomas M. A1 - Spitzer, Klaus A1 - Westhofen, Martin ED - Lehmann, Thomas M. ED - Spitzer, Klaus ED - Tolxdorff, Thomas T1 - Objective Judgement of Endoscopic Laryngeal Images T2 - Advances in Quantitative Laryngoscopy, Voice and Speech Research, Proceedings of the 3rd International Workshop, RWTH Aachen N2 - Video Documentation of endoscopic findings simplifies diagnostic counseling of the patient and aids pre-operative discussion among the medical team. Judgment of such images is still subjective and can not give a quantitative evaluation of the disease process regarding diagnosis or response to treatment. Modern treatment of early laryngeal cancer with laserablation requires intensive follow up and frequent direct laryngoscopy under general anesthesia with blind biopsies to detect any tumor residual or recurrence. Inflammatory conditions of the larynx are frequently confused with other causes of dysphonia. Mapping anddigital analysis of the documented image will suggest the tumor site and avoids undue blind biopsies under anesthesia. However, varying illumination results in different colors reflected from the same object. To achieve quantitative analysis, color constancy has to be assured. Inthis paper, the environment is presented which allow the objective judgment of larngoscopies. KW - Laryngoscopy KW - Diagnosis KW - Image processing KW - Quantitative Image analysis KW - Colorconstancy Y1 - 1998 UR - https://citeseerx.ist.psu.edu/doc_view/pid/caf5bedf5cf68ed3be68054b140a1241f4f278e2 SP - 135 EP - 142 ER - TY - JOUR A1 - Arribas, Julia A1 - Antonelli, Giulio A1 - Frazzoni, Leonardo A1 - Fuccio, Lorenzo A1 - Ebigbo, Alanna A1 - van der Sommen, Fons A1 - Ghatwary, Noha A1 - Palm, Christoph A1 - Coimbra, Miguel A1 - Renna, Francesco A1 - Bergman, Jacques J.G.H.M. A1 - Sharma, Prateek A1 - Messmann, Helmut A1 - Hassan, Cesare A1 - Dinis-Ribeiro, Mario J. T1 - Standalone performance of artificial intelligence for upper GI neoplasia: a meta-analysis JF - Gut N2 - Objective: Artificial intelligence (AI) may reduce underdiagnosed or overlooked upper GI (UGI) neoplastic and preneoplastic conditions, due to subtle appearance and low disease prevalence. Only disease-specific AI performances have been reported, generating uncertainty on its clinical value. Design: We searched PubMed, Embase and Scopus until July 2020, for studies on the diagnostic performance of AI in detection and characterisation of UGI lesions. Primary outcomes were pooled diagnostic accuracy, sensitivity and specificity of AI. Secondary outcomes were pooled positive (PPV) and negative (NPV) predictive values. We calculated pooled proportion rates (%), designed summary receiving operating characteristic curves with respective area under the curves (AUCs) and performed metaregression and sensitivity analysis. Results: Overall, 19 studies on detection of oesophageal squamous cell neoplasia (ESCN) or Barrett's esophagus-related neoplasia (BERN) or gastric adenocarcinoma (GCA) were included with 218, 445, 453 patients and 7976, 2340, 13 562 images, respectively. AI-sensitivity/specificity/PPV/NPV/positive likelihood ratio/negative likelihood ratio for UGI neoplasia detection were 90% (CI 85% to 94%)/89% (CI 85% to 92%)/87% (CI 83% to 91%)/91% (CI 87% to 94%)/8.2 (CI 5.7 to 11.7)/0.111 (CI 0.071 to 0.175), respectively, with an overall AUC of 0.95 (CI 0.93 to 0.97). No difference in AI performance across ESCN, BERN and GCA was found, AUC being 0.94 (CI 0.52 to 0.99), 0.96 (CI 0.95 to 0.98), 0.93 (CI 0.83 to 0.99), respectively. Overall, study quality was low, with high risk of selection bias. No significant publication bias was found. Conclusion: We found a high overall AI accuracy for the diagnosis of any neoplastic lesion of the UGI tract that was independent of the underlying condition. This may be expected to substantially reduce the miss rate of precancerous lesions and early cancer when implemented in clinical practice. KW - Artificial Intelligence Y1 - 2021 U6 - https://doi.org/10.1136/gutjnl-2020-321922 VL - 70 IS - 8 SP - 1458 EP - 1468 PB - BMJ CY - London ER -